Palo Alto Investors »

Elevation Oncology shares owned by Palo Alto Investors

Quarter-by-quarter ownership of Elevation Oncology (ELEV) shares owned by Palo Alto Investors from 13F filings

Historical chart of Palo Alto Investors investment in Elevation Oncology

Tip: Access up to 7 years of quarterly data

All positions including Elevation Oncology held by Palo Alto Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Elevation Oncology by Palo Alto Investors

Quarter filed Position value Share count Share price at filing
2024-03-31 $6.9M 1.3M 5.13

More positions owned by Palo Alto Investors

Insmed Com Par $.01 (INSM)
Amicus Therapeutics (FOLD)
BioMarin Pharmaceutical (BMRN)
Biogen Idec (BIIB)
United Therapeutics Corporation (UTHR)
Staar Surgical Com Par $0.01 (STAA)
ACADIA Pharmaceuticals (ACAD)
Prothena Corp SHS (PRTA)
Iovance Biotherapeutics (IOVA)
Alnylam Pharmaceuticals (ALNY)
Sarepta Therapeutics (SRPT)
Revance Therapeutics (RVNC)
Sage Therapeutics (SAGE)
Anaptysbio Inc Common (ANAB)
eHealth (EHTH)

View all positions for Palo Alto Investors

Top funds holding Elevation Oncology

Farallon Capital Management
Point72 Asset Management
Tang Capital Management
Balyasny Asset Management
Aisling Capital Management
venBio Partners
Braidwell
Qiming U.S. Ventures Management
Darwin Global Management
BVF
Citadel Advisors
Vanguard Group
Artal Group
Hudson Bay Capital Management
Palo Alto Investors

View all funds holding Elevation Oncology